ALL-REMOTE COMPANY/WILMINGTON, Del. / Sep 02, 2025 / Business Wire / Phreesia, a leader in patient activation, today announced the launch of Phreesia VoiceAI, an always-on, intelligent AI phone solution purpose-built for healthcare. VoiceAI leverages advanced natural language processing and real-time workflow integration to help healthcare organizations manage high call volumes, streamline routine interactions and improve the patient experience—all without increasing staff workload.
VoiceAI allows patients to easily resolve common requests by using patients’ natural spoken language. VoiceAI then triages and routes those patient requests accordingly. Calls requiring clinical or administrative follow-up are seamlessly directed to the right team member.
*With supported EMRs
Phreesia VoiceAI supports the most common call types healthcare organizations handle every day—scheduling and referrals, prescription refills, clinical questions, and medical records requests—while also extending to urgent after-hours calls. Whether urgent or routine, calls are managed 24/7: urgent needs are routed directly to on-call physicians through a secure mobile app, while routine requests are captured and documented for timely follow-up.
“Phreesia has always been focused on making healthcare easier for patients, providers and staff,” said CEO Chaim Indig. “VoiceAI is the next big milestone in that journey and a logical extension of our platform, bringing the power of AI to one of the most resource-intensive parts of the practice—the phone—and delivering efficiency and better access for patients. We’re looking forward to continuing to add additional AI-enabled capabilities in the future.”
“The primary reason we chose Phreesia VoiceAI was the significant number of abandoned calls we were experiencing,” said Sumer Allen, Business Intelligence Services Manager at Urology Associates of Mobile. “Since implementation, our abandonment rate has dropped to zero, and patients truly appreciate receiving quick callbacks without the frustration of long wait times.”
About Phreesia
Phreesia is the trusted leader in patient activation, giving healthcare providers, life sciences companies and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled approximately 170 million patient visits in 2024—1 in 7 visits across the U.S.—scale that we believe allows us to make meaningful impact. Offering patient-driven digital solutions for intake, outreach, education and more, Phreesia enhances the patient experience, drives efficiency and improves healthcare outcomes. To learn more, visit phreesia.com.
| Last Trade: | US$23.41 |
| Daily Change: | -0.06 -0.26 |
| Daily Volume: | 482,867 |
| Market Cap: | US$1.400B |
September 04, 2025 September 04, 2025 May 28, 2025 March 12, 2025 December 09, 2024 | |

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREEnd of content
No more pages to load